CymitQuimica logo

CAS 138892-82-7

:

3-Quinolinecarboxylic acid,1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-1,4-dihydro-4-oxo-

Description:
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-1,4-dihydro-4-oxo- is a chemical compound characterized by its complex structure, which includes a quinoline ring system, a carboxylic acid functional group, and a piperazine moiety. This compound typically exhibits properties associated with both heterocyclic compounds and carboxylic acids, such as potential solubility in polar solvents and the ability to participate in hydrogen bonding due to the presence of the carboxylic acid group. The cyclopropyl and piperazine substituents may influence its pharmacological activity, making it of interest in medicinal chemistry. The compound's structure suggests it may have biological activity, possibly as an antimicrobial or anticancer agent, although specific biological properties would require empirical investigation. Additionally, its molecular weight and specific reactivity would depend on the arrangement of its functional groups, which can affect its stability and interactions with other molecules. Overall, this compound represents a unique blend of structural features that may contribute to its potential applications in drug development.
Formula:C19H23N3O3
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
  • Desfluroenrofloxacin HCl

    CAS:
    Formula:C19H23N3O3·HCl
    Molecular weight:341.41 36.46

    Ref: 4Z-E-442

    5mg
    To inquire
    10mg
    To inquire
    25mg
    To inquire
    50mg
    To inquire
    100mg
    To inquire
  • Enrofloxacin 4-Oxo-1,4-dihydroquinoline

    Controlled Product
    CAS:
    Formula:C19H23N3O3
    Color and Shape:Neat
    Molecular weight:341.404

    Ref: TR-E212645

    100mg
    10,511.00€
  • Enrofloxacin impurity C

    CAS:
    <p>Enrofloxacin impurity C is an impurity of enrofloxacin, a drug product. It is a metabolite of enrofloxacin, which has been studied for its effects on the metabolism and pharmacokinetics of this drug. Enrofloxacin impurity C specifically inhibits the activity of CYP3A4 and CYP2C8 in vitro. Enrofloxacin impurity C also has been shown to have niche applications in analytical chemistry as an impurity standard for HPLC analyses.</p>
    Formula:C19H23N3O3
    Purity:Min. 95%
    Color and Shape:Powder
    Molecular weight:341.4 g/mol

    Ref: 3D-IE167733

    2mg
    To inquire
    5mg
    To inquire
    10mg
    To inquire
    25mg
    To inquire
    50mg
    To inquire
  • Enrofloxacin EP Impurity C

    CAS:
    Formula:C19H23N3O3
    Molecular weight:341.41

    Ref: ST-EA-CP-E24003

    10mg
    To inquire
    25mg
    To inquire
    50mg
    To inquire
    100mg
    To inquire